n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine and Body Weight

n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine has been researched along with Body Weight in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Furuya, K; Ginis, I; Hallenbeck, JM; Klimanis, D; Ruetzler, C; Spatz, M; Zimmermann, C	1

Other Studies

1 other study(ies) available for n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine and Body Weight

Article	Year
Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma. Brain research, 2001, Mar-23, Volume: 895, Issue:1-2 Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Blood-Brain Barrier; Body Temperature; Body Weight; Brain; Brain Ischemia; Ceramides; Cerebrovascular Circulation; Disease Models, Animal; Fluorescent Dyes; Interleukin-6; Ischemic Preconditioning; Leukocytes; Lipopolysaccharides; Neuroprotective Agents; Rats; Rats, Inbred SHR; Signal Transduction; Tumor Necrosis Factor-alpha	2001

Article

Year

Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma.

Brain research, 2001, Mar-23, Volume: 895, Issue:1-2

Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Blood-Brain Barrier; Body Temperature; Body Weight; Brain; Brain Ischemia; Ceramides; Cerebrovascular Circulation; Disease Models, Animal; Fluorescent Dyes; Interleukin-6; Ischemic Preconditioning; Leukocytes; Lipopolysaccharides; Neuroprotective Agents; Rats; Rats, Inbred SHR; Signal Transduction; Tumor Necrosis Factor-alpha

2001